These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34966465)

  • 1. Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia.
    Liu CY; Guo HH; Li HX; Liang Y; Tang C; Chen NN
    Dis Markers; 2021; 2021():8223216. PubMed ID: 34966465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
    Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
    BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.
    Cheng Y; Su Y; Wang S; Liu Y; Jin L; Wan Q; Liu Y; Li C; Sang X; Yang L; Liu C; Wang Z
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32751923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia.
    Zeng H; Wu H; Yan M; Tang L; Guo X; Zhao X
    Leuk Res; 2020 Jan; 88():106261. PubMed ID: 31739140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-relatedlncRNAs can predict the prognosis of acute myeloid leukemia.
    Li R; Wu S; Wu X; Zhao P; Li J; Xue K; Li J
    Cancer Med; 2022 Feb; 11(3):888-899. PubMed ID: 34904791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia.
    Zhu Y; He J; Li Z; Yang W
    BMC Bioinformatics; 2023 Feb; 24(1):37. PubMed ID: 36737692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
    Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
    Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
    Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
    Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of tumor protein p53 mutation-based prognostic signatures for acute myeloid leukemia.
    Xie J; Chen K; Han H; Dong Q; Wang W
    Curr Res Transl Med; 2022 Sep; 70(4):103347. PubMed ID: 35483237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 10-Long Non-Coding RNA-Based Expression Signature as a Potential Biomarker for Prognosis of Acute Myeloid Leukemia.
    Tang P; Xie M; Wei Y; Xie X; Chen D; Jiang Z
    Med Sci Monit; 2019 Jul; 25():4999-5004. PubMed ID: 31278736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic impact of abnormally expressed, long noncoding RNAs in acute myeloid leukemia: a meta-analysis.
    Shi J; Shi X; Dai RQ
    Hematology; 2020 Dec; 25(1):219-228. PubMed ID: 33346694
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive long non-coding RNA expression profiling by RNA sequencing reveals potential biomarkers for acute myeloid leukemia risk.
    Wang Y
    Cancer Biomark; 2019; 26(1):93-108. PubMed ID: 31356197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia.
    Zhao C; Wang Y; Sharma A; Wang Z; Zheng C; Wei Y; Wu Y; Liu P; Liu J; Zhan X; Schmidt-Wolf I; Tu F
    Cancer Invest; 2022 Sep; 40(8):663-674. PubMed ID: 35770858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five cuprotosis-related lncRNA signatures for prognosis prediction in acute myeloid leukaemia.
    Wang Q
    Hematology; 2023 Dec; 28(1):2231737. PubMed ID: 37417765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia.
    Pan JQ; Zhang YQ; Wang JH; Xu P; Wang W
    Int J Mol Med; 2017 Mar; 39(3):663-671. PubMed ID: 28204819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.
    Zheng J; Song Y; Li Z; Tang A; Fei Y; He W
    Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia.
    Papaioannou D; Nicolet D; Ozer HG; Mrózek K; Volinia S; Fadda P; Carroll AJ; Kohlschmidt J; Kolitz JE; Wang ES; Stone RM; Byrd JC; Garzon R; Bloomfield CD
    Mol Cancer Ther; 2019 Aug; 18(8):1451-1459. PubMed ID: 31164409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.